UBS Group: Omega Healthcare OHI Historial de posiciones en acciones
Comprado
Mantenidas
Vendido
| Trimestre | Valor de mercado | Estado | Acciones |
Cambio en la posición | Valor operado | Peso en el portafolio | Puesto en el portafolio | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 142 M | Compra |
3,057,958
+804,220
| +36% | +USD 38.5 M | 0.02% | 858 |
|
|
2026
Q2 | USD 107 M | Compra |
2,253,738
+783,102
| +53% | +USD 36.3 M | 0.01% | 1070 |
|
|
2026
Q1 | USD 64.4 M | Venta |
1,470,636
-358,019
| -20% | -USD 16.3 M | 0.01% | 1390 |
|
|
2025
Q4 | USD 81.1 M | Compra |
1,828,655
+426,409
| +30% | +USD 18.4 M | 0.01% | 1180 |
|
|
2025
Q3 | USD 59.2 M | Venta |
1,402,246
-802,048
| -36% | -USD 32.3 M | 0.01% | 1456 |
|
|
2025
Q2 | USD 80.8 M | Compra |
2,204,294
+317,009
| +17% | +USD 11.8 M | 0.01% | 1122 |
|
|
2025
Q1 | USD 71.9 M | Compra |
1,887,285
+273,466
| +17% | +USD 10.2 M | 0.01% | 1156 |
|
|
2024
Q4 | USD 61.1 M | Compra |
1,613,819
+1,287,407
| +394% | +USD 51.4 M | 0.01% | 1284 |
|
|
2024
Q3 | USD 13.3 M | Compra |
326,412
+80,946
| +33% | +USD 3.06 M | ﹤0.01% | 2135 |
|
|
2024
Q2 | USD 8.41 M | Venta |
245,466
-124,337
| -34% | -USD 3.92 M | ﹤0.01% | 2365 |
|
|
2024
Q1 | USD 11.7 M | Venta |
369,803
-79,313
| -18% | -USD 2.41 M | ﹤0.01% | 2144 |
|
|
2023
Q4 | USD 13.8 M | Compra |
449,116
+334,634
| +292% | +USD 10.7 M | ﹤0.01% | 1850 |
|
|
2023
Q3 | USD 3.8 M | Venta |
114,482
-347,643
| -75% | -USD 11.1 M | ﹤0.01% | 2844 |
|
|
2023
Q2 | USD 14.2 M | Venta |
462,125
-59,910
| -11% | -USD 1.73 M | ﹤0.01% | 1717 |
|
|
2023
Q1 | USD 14.3 M | Venta |
522,035
-296,646
| -36% | -USD 8.26 M | 0.01% | 1643 |
|
|
2022
Q4 | USD 22.9 M | Compra |
818,681
+450,608
| +122% | +USD 13.6 M | 0.01% | 1315 |
|
|
2022
Q3 | USD 10.9 M | Venta |
368,073
-38,951
| -10% | -USD 1.22 M | ﹤0.01% | 1717 |
|
|
2022
Q2 | USD 11.5 M | Compra |
407,024
+36,097
| +10% | +USD 1.03 M | ﹤0.01% | 1714 |
|
|
2022
Q1 | USD 11.6 M | Venta |
370,927
-80,157
| -18% | -USD 2.36 M | ﹤0.01% | 1831 |
|
|
2021
Q4 | USD 13.3 M | Venta |
451,084
-221,263
| -33% | -USD 6.46 M | ﹤0.01% | 1894 |
|
|
2021
Q3 | USD 20.1 M | Compra |
672,347
+161,712
| +32% | +USD 5.56 M | 0.01% | 1498 |
|
|
2021
Q2 | USD 18.5 M | Compra |
510,635
+21,976
| +4% | +USD 816 k | 0.01% | 1545 |
|
|
2021
Q1 | USD 17.9 M | Compra |
488,659
+9
| +0% | +USD 331 | 0.01% | 1520 |
|
|
2020
Q4 | USD 17.7 M | Venta |
488,650
-140,548
| -22% | -USD 4.76 M | 0.01% | 1422 |
|
|
2020
Q3 | USD 18.8 M | Compra |
629,198
+329,241
| +110% | +USD 10.3 M | 0.01% | 1208 |
|
|
2020
Q2 | USD 8.92 M | Venta |
299,957
-187,770
| -38% | -USD 5.56 M | ﹤0.01% | 1592 |
|
|
2020
Q1 | USD 12.9 M | Venta |
487,727
-643,815
| -57% | -USD 24.4 M | 0.01% | 1233 |
|
|
2019
Q4 | USD 47.9 M | Compra |
1,131,542
+349,218
| +45% | +USD 14.8 M | 0.02% | 805 |
|
|
2019
Q3 | USD 32.7 M | Compra |
782,324
+160,548
| +26% | +USD 6.25 M | 0.01% | 915 |
|
|
2019
Q2 | USD 22.8 M | Compra |
621,776
+109,236
| +21% | +USD 3.98 M | 0.01% | 1129 |
|
|
2019
Q1 | USD 19.6 M | Compra |
512,540
+12,500
| +2% | +USD 463 k | 0.01% | 1161 |
|
|
2018
Q4 | USD 17.6 M | Compra |
500,040
+58,842
| +13% | +USD 2.04 M | 0.01% | 1171 |
|
|
2018
Q3 | USD 14.5 M | Venta |
441,198
-21,334
| -5% | -USD 679 k | 0.01% | 1456 |
|
|
2018
Q2 | USD 14.3 M | Compra |
462,532
+66,754
| +17% | +USD 1.91 M | 0.01% | 1418 |
|
|
2018
Q1 | USD 10.7 M | Venta |
395,778
-37,908
| -9% | -USD 1.01 M | ﹤0.01% | 1624 |
|
|
2017
Q4 | USD 11.9 M | Venta |
433,686
-55,637
| -11% | -USD 1.61 M | ﹤0.01% | 1585 |
|
|
2017
Q3 | USD 15.6 M | Compra |
489,323
+170,942
| +54% | +USD 5.48 M | 0.01% | 1280 |
|
|
2017
Q2 | USD 10.5 M | Venta |
318,381
-71,618
| -18% | -USD 2.37 M | 0.01% | 1494 |
|
|
2017
Q1 | USD 12.9 M | Compra |
389,999
+197,449
| +103% | +USD 6.34 M | 0.01% | 1304 |
|
|
2016
Q4 | USD 6.02 M | Venta |
192,550
-55,295
| -22% | -USD 1.71 M | ﹤0.01% | 1929 |
|
|
2016
Q3 | USD 8.79 M | Venta |
247,845
-38,883
| -14% | -USD 1.38 M | 0.01% | 1527 |
|
|
2016
Q2 | USD 9.7 M | Compra |
286,728
+122,133
| +74% | +USD 4.08 M | 0.01% | 1397 |
|
|
2016
Q1 | USD 5.81 M | Compra |
164,595
+23,101
| +16% | +USD 757 k | ﹤0.01% | 1741 |
|
|
2015
Q4 | USD 4.95 M | Compra |
141,494
+24,747
| +21% | +USD 855 k | ﹤0.01% | 1976 |
|
|
2015
Q3 | USD 4.1 M | Venta |
116,747
-27,981
| -19% | -USD 983 k | ﹤0.01% | 2081 |
|
|
2015
Q2 | USD 4.97 M | Venta |
144,728
-111,405
| -43% | -USD 4.09 M | ﹤0.01% | 2086 |
|
|
2015
Q1 | USD 10.4 M | Venta |
256,133
-202,474
| -44% | -USD 8.38 M | 0.01% | 1448 |
|
|
2014
Q4 | USD 17.9 M | Compra |
+458,607
| Nuevas | +USD 17.4 M | 0.01% | 1074 |
|
Otros fondos que tienen OHI en su portafolio
Posición de UBS Group en OHI: resumen de T3 2026
UBS Group aumentó su participación en Omega Healthcare (OHI) en 36% durante T3 2026, al comprar aproximadamente USD 38.5 M y elevar la posición a 3,057,958 acciones con un valor de USD 142 M. La posición representa 0.02% del portafolio y ocupa el puesto #858.
UBS Group reportó por primera vez una posición en OHI en T4 2014 y desde entonces la ha mantenido en 48 trimestres. Al cierre de T3 2026, 768 fondos que sigue Wall St. Rank mantienen una posición en OHI.
- Al cierre de T3 2026, UBS Group tenía 3,057,958 acciones de Omega Healthcare con un valor de USD 142 M.
- UBS Group compró 804,220 acciones de Omega Healthcare en T3 2026, por un monto estimado de USD 38.5 M.
- Omega Healthcare representó el 0.02% del portafolio de UBS Group en T3 2026 y fue su posición número 858.
- UBS Group reportó por primera vez una posición en Omega Healthcare en T4 2014 y desde entonces la ha mantenido en 48 trimestres.
- Al cierre de T3 2026, 768 fondos que sigue Wall St. Rank tenían Omega Healthcare en su portafolio.
Según el informe 13F de UBS Group correspondiente a T3 2026, presentado el 10 nov 2026.